BioWorld MedTech

April 14, 2014

New Boston Sci registry to evaluate Vercise DBS in Parkinson's patients

Boston Scientific (Natick, Massachusetts) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise deep brain stimulation (DBS) system in patients with Parkinson's disease. Read More

Report from Israel: Nazareth incubator NGT3 raising funds with lofty dual agenda

Washington Roundup: FDA nod to Block HF adds 800K to market for biventricular pacing

MDD's Stock Watch

Report from Europe: Focus shifts from sales to costs for French startups

Court Report: Varian settles patent litigation with University of Pittsburgh for $35M

Deals Roundup: Covidien in plan to acquire New Wave Surgical for $100M

Report from Europe: Seno awarded CE mark for Imagio imaging system

Financings roundup: Ventas prices public offering of senior notes

Sebelius out at HHS, but Burwell unlikely to steer different course

People in Places

Briefly Noted

Product briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...